I. Offermann

发表

Should Corticosteroids Be Considered as Part of the Standard Care With Photodynamic Therapy

U. Schmidt-Erfurth, A. Augustin, Gillies Mc, 2017 .

Mçglichkeiten und Grenzen der innovativen Vitrektomiesysteme Scope and Limititions of Innovative Vitrectomy Systems

A. Augustin, I. Offermann, 2007 .

COMPARISON OF THE ORIGINAL AMSLER GRID WITH THE MODIFIED AMSLER GRID: Result for Patients With Age-Related Macular Degeneration

U. Schmidt-Erfurth, A. Augustin, ALBERT J. AUGUSTIN, 2005, Retina.

Prevalence and molecular diversity of pHS-2 plasmids, marker for arthritogenicity, among clinical Escherichia coli Shigella isolates.

J. Sieper, H. Tschäpe, T. Adam, 2003, Microbes and infection.

Emerging drugs for age-related macular degeneration

A. Augustin, I. Offermann, 2006, Expert opinion on emerging drugs.

TRIPLE THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION: Verteporfin PDT, Bevacizumab, and Dexamethasone

A. Augustin, I. Offermann, S. Puls, 2007, Retina.

[Are Hegar's rods omissible? (author's transl)].

M. Breckwoldt, E. Petersen, H. Zahradnik, 1979, Geburtshilfe und Frauenheilkunde.

[The significance of oxidative mechanisms in diseases of the retina].

U. Schmidt-Erfurth, A. Augustin, H. Dick, 2002, Klinische Monatsblatter fur Augenheilkunde.

Combination Therapy for Choroidal Neovascularisation

A. Augustin, I. Offermann, 2007, Drugs & aging.